Patents by Inventor Dino De Cicco

Dino De Cicco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190282783
    Abstract: Systems, devices, and methods for using an intraluminal sensing device are provided. The intraluminal sensing device may include a ferrous element disposed at a distal portion of an elongate flexible member configured to be placed in a body lumen of a patient. An external electromagnetic field device may be used to produce an electromagnetic field that may be used to direct the movement of the flexible elongate member within the body lumen.
    Type: Application
    Filed: March 12, 2019
    Publication date: September 19, 2019
    Inventor: DINO DE CICCO
  • Publication number: 20190046156
    Abstract: Devices, systems, and methods for evaluating a vessel and tracking progression of an intravascular procedure are disclosed. In an embodiment, a medical system is disclosed. One embodiment of the medical system comprises a medical processing unit in communication with an intravascular device configured to obtain intravascular ultrasound (IVUS) data and with an external ultrasound device configured to obtain external ultrasound data. The medical processing unit is configured to receive the IVUS data from the intravascular device, wherein the intravascular device is positioned proximate to an aneurysm, receive the external ultrasound data from the external ultrasound device, wherein the external ultrasound device is positioned to image the aneurysm, and track progression of a coil embolization of the aneurysm based on the IVUS data and the external ultrasound data.
    Type: Application
    Filed: August 10, 2018
    Publication date: February 14, 2019
    Inventors: Dino DE CICCO, John UNSER
  • Publication number: 20190029642
    Abstract: Intravascular ultrasound (IVUS) imaging devices, systems, and method are provided. In one embodiment, an IVUS imaging device includes a flexible elongate member configured to be positioned within a lumen of a patient, the flexible elongate member comprising a proximal portion and a distal portion; and an imaging assembly disposed at the distal portion of the flexible elongate member. The imaging assembly includes a first ultrasound transducer operating at a first center frequency; and a second ultrasound transducer operating at a second center frequency different from the first center frequency.
    Type: Application
    Filed: July 27, 2018
    Publication date: January 31, 2019
    Inventors: DINO DE CICCO, ERIC KHAIRY, DAVID GOODMAN
  • Publication number: 20190029702
    Abstract: Embolism treatment devices, systems, and methods are provided. In one embodiment, an embolism treatment system includes a flexible elongate member configured to be positioned within a blood vessel of a patient, the flexible elongate member comprising a distal portion and a proximal portion; an ultrasound imaging component positioned at the distal portion and configured to emit ultrasound energy towards a blood clot within the blood vessel and collect an image signal representative of the blood clot; a treatment component positioned at the distal portion and configured to treat the blood clot; and a flow sensing component positioned at the distal portion and configured to determine a blood flow measurement within the blood vessel associated with the blood clot.
    Type: Application
    Filed: July 28, 2018
    Publication date: January 31, 2019
    Inventors: DINO DE CICCO, DAVID GOODMAN
  • Publication number: 20170100112
    Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes an occlusion member and may also include a stabilizing member. The stabilizing member inhibits compression of the left atrial appendage, facilitating tissue in-growth onto the occlusion member. Methods are also disclosed.
    Type: Application
    Filed: October 25, 2016
    Publication date: April 13, 2017
    Applicant: ATRITECH, INC.
    Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G.C. Frazier, Alexander K. Khairkhahan, Marc S. Kreidler, Michael D. Lesh, Chad C. Roue
  • Publication number: 20160106437
    Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes an occlusion member and may also include a stabilizing member. The stabilizing member inhibits compression of the left atrial appendage, facilitating tissue in-growth onto the occlusion member. Methods are also disclosed.
    Type: Application
    Filed: October 26, 2015
    Publication date: April 21, 2016
    Applicant: ATRITECH, INC.
    Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G.C. Frazier, Alex K. Khairkhahan, Marc S. Kriedler, Michael D. Lesh, Chad C. Roue
  • Publication number: 20160051323
    Abstract: The invention provides devices with integrated intravascular imaging and methods for crossing a CTO within the true lumen of a vessel. An interventional catheter with intravascular imaging capabilities can be guided into an affected vessel and to a CTO. An included intravascular imaging device captures a 3D image of the environment. The catheter includes a crossing member that can be extended out from a distal tip of the catheter, causing the crossing member to directly cross through the CTO creating a new channel through the CTO.
    Type: Application
    Filed: August 21, 2015
    Publication date: February 25, 2016
    Inventors: Jeremy Stigall, John Unser, Dino De Cicco, Maritess Minas
  • Publication number: 20160015422
    Abstract: The invention provides methods and devices for treating liver cirrhosis or portal hypertension by creating an intrahepatic shunt, or new passage, from a portal vein of a patient to a hepatic vein using a device with intravascular imaging capabilities and pressure sensing capabilities or positioning mechanisms. The integration of intravascular imaging aids in the precise placement of the shunt and pressure measurement may verify successful shunt creation. An apparatus may include a catheter with an extended body for insertion into a hepatic vein of a patient, an intravascular imaging device and a needle exit port on the distal portion of the extended body, and a needle disposed within a lumen in the catheter and configured to be pushed out of the exit port and extend away from a side of the extended body, in which the needle includes a pressure sensor.
    Type: Application
    Filed: July 15, 2015
    Publication date: January 21, 2016
    Inventors: Dino De Cicco, Jeremy Stigall, John Unser
  • Patent number: 9168043
    Abstract: Disclosed is a method of preventing atrial appendage thrombus from entering the blood stream in which an occlusion device placed within the left atrial appendage inhibits compression of the left atrial appendage and facilitates tissue in-growth onto the occlusion member. The occlusion device includes an occlusion member, a plurality of supports and a plurality of barbs associated with the plurality of supports.
    Type: Grant
    Filed: August 14, 2013
    Date of Patent: October 27, 2015
    Assignee: ATRITECH, INC.
    Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G. C. Frazier, Alex K. Khairkhahan, Marc S. Kriedler, Michael D. Lesh, Chad C. Roue
  • Patent number: 8986241
    Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, aspirate clot and fluid, and allow passage of a guidewire. Optionally, the catheter may also include a mechanical agitator for further disrupt clot in the presence of the thrombolytic agent. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.
    Type: Grant
    Filed: September 12, 2013
    Date of Patent: March 24, 2015
    Assignee: Covidien LP
    Inventors: Michael A. Evans, Denise Zarins, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang
  • Publication number: 20140336699
    Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes an occlusion member and may also include a stabilizing member. The stabilizing member inhibits compression of the left atrial appendage, facilitating tissue in-growth onto the occlusion member. Methods are also disclosed.
    Type: Application
    Filed: May 12, 2014
    Publication date: November 13, 2014
    Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G.C. Frazier, Marc S. Kreidler, Michael D. Lesh, Chad C. Roue, Alexander K. Khairkhahan
  • Patent number: 8834519
    Abstract: A device and method for obliterating or occluding a body cavity or passageway, in particular, the left atrial appendage of a patient's heart. The procedure can be carried out intraoperatively, but is preferably carried out percutaneously by use of a delivery catheter to position an occluding device adjacent a patient's left atrial appendage. The occluding device may prevent the passage of embolic or other material to or from the left atrial appendage by volumetrically filling the appendage, closing the opening of the appendage with an occluding member, or pulling the tissue around the opening of the appendage together and fixing it in a closed state.
    Type: Grant
    Filed: November 18, 2011
    Date of Patent: September 16, 2014
    Assignee: Artritech, Inc.
    Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G. C. Frazier, Alexander K. Khairkhahan, Marc S. Kreidler, Michael D. Lesh, Chad C. Roue
  • Publication number: 20140171911
    Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, aspirate clot and fluid, and allow passage of a guidewire. Optionally, the catheter may also include a mechanical agitator for further disrupt clot in the presence of the thrombolytic agent. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.
    Type: Application
    Filed: September 12, 2013
    Publication date: June 19, 2014
    Applicant: Covidien LP
    Inventors: Michael A. Evans, Denise Demarais, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang
  • Publication number: 20140046360
    Abstract: An implantable device for containing emboli within an atrial appendage may include an expandable frame having a plurality of supports projecting distally from a proximal hub, a mesh barrier provided on proximal sections of the supports, and a plurality of tissue anchors provided on the supports for engaging tissue when the device is positioned in an atrial appendage.
    Type: Application
    Filed: September 3, 2013
    Publication date: February 13, 2014
    Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G.C. Frazier, Alex K. Khairkahan, Marc S. Kriedler, Michael D. Lesh, Chad C. Roue
  • Publication number: 20130331884
    Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes a pumpable injectable material and a retention member having a tissue penetrating shaft which extends from a proximal end of the device to a distal end of the device.
    Type: Application
    Filed: August 14, 2013
    Publication date: December 12, 2013
    Inventors: Erik J. Van der Burg, Dino De Cicco, Andrew G.C. Frazier, Alex K. Khairkahan, Marc S. Kriedler, Michael D. Lesh, Chad C. Roue
  • Patent number: 8535290
    Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, aspirate clot and fluid, and allow passage of a guidewire. Optionally, the catheter may also include a mechanical agitator for further disrupt clot in the presence of the thrombolytic agent. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.
    Type: Grant
    Filed: July 13, 2012
    Date of Patent: September 17, 2013
    Assignee: Covidien LP
    Inventors: Michael A. Evans, Denise Demarais, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang
  • Patent number: 8535343
    Abstract: Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes a pumpable injectable material and a retention member having a tissue penetrating shaft which extends from a proximal end of the device to a distal end of the device.
    Type: Grant
    Filed: May 17, 2011
    Date of Patent: September 17, 2013
    Assignee: Atritech, Inc.
    Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G. C. Frazier, Alex K. Khairkahan, Marc S. Kriedler, Michael D. Lesh, Chad C. Roue
  • Patent number: 8523897
    Abstract: An implantable device for containing emboli within an atrial appendage may include an expandable frame having a plurality of supports projecting distally from a proximal hub, a mesh barrier provided on proximal sections of the supports, and a plurality of tissue anchors provided on the supports for engaging tissue when the device is positioned in an atrial appendage.
    Type: Grant
    Filed: September 27, 2006
    Date of Patent: September 3, 2013
    Assignee: Atritech, Inc.
    Inventors: Erik J. van der Burg, Dino De Cicco, Andrew G. C. Frazier, Alex K. Khairkahan, Marc S. Kriedler, Michael D. Lesh, Chad C. Roue
  • Publication number: 20120283699
    Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, aspirate clot and fluid, and allow passage of a guidewire. Optionally, the catheter may also include a mechanical agitator for further disrupt clot in the presence of the thrombolytic agent. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.
    Type: Application
    Filed: July 13, 2012
    Publication date: November 8, 2012
    Applicant: TYCO HEALTHCARE GROUP LP
    Inventors: Michael A. Evans, Denise Demarais, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang
  • Patent number: 8241241
    Abstract: Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, aspirate clot and fluid, and allow passage of a guidewire. Optionally, the catheter may also include a mechanical agitator for further disrupt clot in the presence of the thrombolytic agent. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.
    Type: Grant
    Filed: June 15, 2010
    Date of Patent: August 14, 2012
    Assignee: Tyco Healthcare Group LP
    Inventors: Michael A. Evans, Denise Demarias, Dino De Cicco, Kelvin Ning, Alexander Khairkhahan, Tyler Jon Strang